Clinical Trials Insight: 700014349
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2008
At a glance
- Drugs ATHX 105 (Primary)
- Indications Obesity
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Athersys
- 27 Feb 2008 Status changed from initiated to completed as reported by Athersys.
- 27 Feb 2008 Results have been reported by Athersys.
- 25 Jul 2007 Status changed from planning to initiated.